13. 多発性硬化症／視神経脊髄炎 Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details
臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00688948 (ClinicalTrials.gov) | November 2007 | 30/5/2008 | Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS) | A Pilot Study Looking At The Use Of Alfuzosin In The Treatment Of Bladder Dysfunction In Patients With Multiple Sclerosis | Multiple Sclerosis;Bladder Dysfunction | Drug: Alfuzosin | Capital District Health Authority, Canada | Sanofi | Terminated | 18 Years | N/A | Both | 20 | Phase 2/Phase 3 | Canada |